首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Acta pharmacologica sinica

缩写:ACTA PHARMACOL SIN

ISSN:1671-4083

e-ISSN:1745-7254

IF/分区:8.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3638
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Javier Jurado-Aguilar,Emma Barroso,Patricia Rada et al. Javier Jurado-Aguilar et al.
Metformin, the most prescribed drug for the treatment of type 2 diabetes mellitus, increases the circulating levels of the metabolic regulator growth differentiation factor 15 (GDF15) via transcriptional regulation, with the kidneys being r...
Ming-Jia Yu,Rui-Qi Xiong,Jing-Wen Wu et al. Ming-Jia Yu et al.
Cerebral edema is a severe complication following ischemic stroke. Recent studies have highlighted the crucial role of the glymphatic system (GS) in the clearance of water and macromolecules. GS dysfunction involving the disorders of AQP4 p...
Hai-Bo Li,Yong-Hui Liu,Hai Liu et al. Hai-Bo Li et al.
The high relapse rate of drugs is currently a therapeutic dilemma in the treatment of substance use disorder (SUD). Emerging evidence from preclinical animal models demonstrates that pretreatment with selective dopamine D2 receptor (D2R) an...
Xiao-Jun Zhao,Yang Xu,Cong-Hui Zhang et al. Xiao-Jun Zhao et al.
Mitochondrial DNA (mtDNA) mutations are the most common cause in aberrant mitochondrion-leading cancer, exploration of direct targeting mutated mtDNA still remains incomplete. Secoemestrin C (Sec C) is epitetrathiodioxopiperazine derived fr...
Tong-Han Zhang,Jin-Tao Zhu,Zhi-Xian Huang et al. Tong-Han Zhang et al.
Targeted covalent inhibitors (TCIs) are emerging as a new modality in drug discovery because of their strong binding affinity and prolonged target engagement. However, the rational design of TCIs remains a significant challenge and is hinde...
Xiao-Yu Wang,Wen-Shu Zhou,Uma Gaur et al. Xiao-Yu Wang et al.
The sigma-1 receptor is an important new therapeutic drug target for Alzheimer's disease (AD). Here, we reported that SOMCL-668, a novel selective and potent sigma-1 receptor allosteric modulator, is neuroprotective in AD both in vitro and ...
Meng-Ping Lou,Xin-Yi Gao,He-Ting Yan et al. Meng-Ping Lou et al.
Chronic itch is a debilitating symptom of atopic dermatitis (AD). Current therapeutic approaches for managing this condition include topical and systemic pharmacological agents with inconsistent efficacy and potential adverse effects. Sopho...
Tian-Jiao Shan,Lan-Ya Li,Xiao-Ya Wan et al. Tian-Jiao Shan et al.
Targeting the IGF1 system holds promise as a therapeutic approach for breast cancer. However, the intricate nature of IGF1 signaling and suboptimal drug combinations have resulted in limited clinical success. This study demonstrates that si...
Wen-Han Wu,Yi-Dong Dai,Wen-Ke Feng et al. Wen-Han Wu et al.
Atypical antipsychotics often cause hyperglycemia, with clozapine showing the highest risk. Metformin is a first-line medication for managing diabetes or prediabetes and is often used to control clozapine-induced hyperglycemia. Clinical stu...
Yang Wang,Yi Sun,Chang-Yuan Wang et al. Yang Wang et al.
Metabolic dysfunction-associated steatohepatitis (MASH), an inflammatory subtype of metabolic dysfunction-associated fatty liver disease (MAFLD), drives hepatic dysfunction and poses a significant health burden. Lipophagy dysfunction disrup...